SCHEMBL1374828

SCHEMBL1374828

CC(C)(C)OC(=O)N1C[C@H](Cc2ccsc2)C[C@H]1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.37
GRM3 Q14832 1/20 0.37
UCHL1 P09936 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
NR1H2 P55055 3/20 0.36
NR1H3 Q13133 2/20 0.36
ACE P12821 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
AGTR2 P50052 4/20 0.35
HSD11B1 P28845 1/20 0.35
CYP2C9 P11712 1/20 0.35
GPR119 Q8TDV5 1/20 0.35
HTRA1 Q92743 1/20 0.35
MEN1 O00255 1/20 0.34
KDM4A O75164 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13687997 0.85 NR1H2 (0.48) NR1H2NR1H3ACEAGTR2MCL1
SCHEMBL21409001 0.85 NR1H2 (0.48) NR1H2NR1H3ACEAGTR2MCL1
SCHEMBL6183345 0.85 NR1H2 (0.48) NR1H2NR1H3ACEAGTR2MCL1
SCHEMBL1373084 0.85 NR1H2 (0.48) NR1H2NR1H3ACEAGTR2MCL1
SCHEMBL7285245 0.85 NR1H2 (0.48) NR1H2NR1H3ACEAGTR2MCL1
SCHEMBL6183348 0.85 NR1H2 (0.48) NR1H2NR1H3ACEAGTR2MCL1
SCHEMBL9542940 0.85 NR1H2 (0.48) NR1H2NR1H3ACEAGTR2MCL1
SCHEMBL1371521 0.83 CYP2C19 (0.44) CTSSCTSKNR1H2NR1H3ACE
SCHEMBL27190612 0.83 CYP2C19 (0.44) CTSSCTSKNR1H2NR1H3ACE
SCHEMBL2171522 0.83 CYP2C19 (0.44) CTSSCTSKNR1H2NR1H3ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791102-B2 Acetanilide sphingosine-1-phosphate receptor antagonists EXELIXIS, INC. (US) 2014-07-29 US disclosed
US-20110288076-A1 Sphingosine-1-Phosphate Receptor Antagonists EXELIXIS, INC. (US) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288076-A1 Sphingosine-1-Phosphate Receptor Antagonists S1PR1, S1PR2, S1PR3 GRM2 305/4885GRM3 211/4885UCHL1 4616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.